OPIOID ANTAGONIST DISTRIBUTION                                     S.B. 1170 & 1171:

                                                                                         SUMMARY OF BILL

                                                                         REPORTED FROM COMMITTEE

Senate Bills 1170 and 1171 (as reported without amendment)

Sponsor:  Senator Curtis S. VanderWall

Committee:  Health Policy and Human Services

CONTENT

Senate Bill 1170 would amend the Administration of Opioid Antagonists Act to specify that an agency that purchased or otherwise obtained and possessed an opioid antagonist or an employee or agency of an agency who possessed an opioid antagonist distributed to that employee or agency could distribute that opioid antagonist directly or indirectly to any individual.

Senate Bill 1171 would amend the Public Health Code to allow a prescriber to issue a prescription for and a dispensing prescriber or pharmacist to dispense an opioid antagonist to an agency authorized to obtain an opioid antagonist under the Administration of Opioid Antagonists Act.

The bills are tie-barred.

MCL 15.673 et al. (S.B. 1170)                 Legislative Analyst:  Stephen P. Jackson

       333.17744b (S.B. 1171)

FISCAL IMPACT

The bills could have a positive fiscal impact on the State and local governments. The immunity provisions could reduce the number of prosecutions and convictions for possession or administration of controlled substances by employees or agents, which could reduce court and corrections costs and costs of litigation for an agency that obtained opioid antagonists and trained agents or employees in the administration of opioid antagonists.

Date Completed:  11-21-22                                    Fiscal Analyst:  Ryan Bergan

This analysis was prepared by nonpartisan Senate staff for use by the Senate in its deliberations and does not constitute an official statement of legislative intent.